Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Technology imitating life

23.02.2006


Scientists from Leicester have discovered a radical new approach to making artificial platelets to help stop bleeding in patients who have too few platelets of their own. This invention could be a major breakthrough for cancer patients suffering from severe or life threatening bleeding.



The development of this highly innovative product has been made possible thanks to a major funding round of £3.1m led by Quester, including investment from NESTA (the National Endowment for Science, Technology and the Arts), and the East Midlands Regional Venture Capitalist Fund.

As well as providing money in this funding round, NESTA has played an important role in providing vital seed finance, bridging the gap between the two rounds.


Platelets are blood cells, essential for the blood to clot. When patients suffer from platelet deficiency, blood clots cannot form properly and this can lead to life threatening bleeding. This is a particularly serious problem for patients with leukaemia and those receiving cancer therapy.

The development of the Haemostatix artificial platelets - Haemoplax - has been driven by an urgent need to find a more cost effective, safer, virus-free alternative to platelet transfusion.

The transfusion of platelets prepared from blood donations by Blood Transfusion Services is currently the only available treatment. One big drawback of this method is the potential for passing on infectious agents from donors to recipients, and recently, concerns about the potential risk of transmission of CJD (human BSE) are threatening the supply of platelets for transfusion. Platelets are also expensive to produce, have a shelf life of only five days, and need to be screened to remove the risk of transmission of blood-borne viruses that cause hepatitis and HIV.

Mark White, NESTA Invention and Innovation Director, said: “NESTA is well placed to identify innovative companies at the earliest stage of development and we are delighted to now have Quester and the East Midlands Regional Venture Capital Fund on board as co-investors. They have recognised, along with us, that Haemostatix is a classic illustration of a British firm which is successfully exploiting world-class science.”

Haemostatix, a spin-out from Leicester University, was founded in 2003 by Sarah Middleton (CEO) and Professor Alison Goodall (CSO) in conjunction with the University of Leicester which played a crucial supporting role in the company’s early stages.

Joseph Meaney | alfa
Further information:
http://www.nesta.org.uk

More articles from Life Sciences:

nachricht More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>